Fritextsökning
Innehållstyper
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Satsar på USA
Braincool lämnar in en marknadsansökan till FDA och förbereder lansering.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Sundin ger miljoner till forskning
Finansierar tjänster i Solna och Toronto.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Känsligare än PSA
Ett nytt test för prostatacancer ska tas i bruk på Karolinska Universitetslaboratoriet i mars nästa år.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Sjukvården måste göra sig redo för genombrott
Vi står inför en medicinsk revolution, men är sjukvården redo? Det undrar Anders Blanck, vd för Lif.
-
Hon får europeiskt forskningspris
Umeåforskaren Emmanuelle Charpentier prisas för sitt bidrag till upptäckten av en mekanism i bakteriers eget immunsystem som lagt grunden till en ny teknik för ...
-
Myriaddom kan upphäva Hesc-patent
De rättsliga striderna kring patent på biologiskt material tar ny fart.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Sales Representative, Applied Biosystems
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Immunovia i nytt samarbete
Tecknar avtal med andra centret inför en klinisk studie med sitt diagnostiska test för pankreascancer.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.